Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0053 | 0.8535 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.2346 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0061 | 1 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.3387 | 0.3969 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.3387 | 0.4955 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.2346 | 0.2188 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.129 | 0.1887 |
Echinococcus granulosus | dna polymerase kappa | 0.0019 | 0.2346 | 0.2188 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0061 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0042 | 0.6578 | 0.6578 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.2346 | 0.3432 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0042 | 0.6578 | 0.6508 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.6578 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0061 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.6836 | 0.6836 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0044 | 0.6836 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0031 | 0.449 | 0.5261 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0019 | 0.2346 | 0.2346 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.129 | 0.1887 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.051 | 0.0315 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.3387 | 0.3387 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.129 | 0.1887 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.051 | 0.0315 |
Schistosoma mansoni | DNA polymerase eta | 0.0044 | 0.6836 | 0.6836 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.2346 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0019 | 0.2346 | 0.2346 |
Leishmania major | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.2346 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.3387 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.3387 | 0.4955 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0042 | 0.6578 | 0.6508 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 1 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0044 | 0.6836 | 0.6771 |
Echinococcus granulosus | cpg binding protein | 0.003 | 0.4295 | 0.4178 |
Brugia malayi | CXXC zinc finger family protein | 0.0028 | 0.4007 | 0.4007 |
Brugia malayi | TAR-binding protein | 0.0061 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0031 | 0.449 | 0.6568 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.6578 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.6578 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0019 | 0.2346 | 0.2346 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.2346 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0011 | 0.0937 | 0.0937 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Echinococcus multilocularis | cpg binding protein | 0.003 | 0.4295 | 0.4178 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0061 | 1 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.2346 | 0.5 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0028 | 0.4007 | 0.4007 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0044 | 0.6836 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0019 | 0.2346 | 0.3432 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0044 | 0.6836 | 0.6836 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.006 | 0.9682 | 0.9682 |
Leishmania major | DNA polymerase eta, putative | 0.0031 | 0.449 | 0.6568 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0013 | 0.129 | 0.1887 |
Loa Loa (eye worm) | RNA binding protein | 0.0061 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.3387 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.3387 | 0.4955 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.2346 | 0.3432 |
Brugia malayi | hypothetical protein | 0.0016 | 0.1813 | 0.1813 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0009 | 0.049 | 0.049 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.3387 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.6578 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.2346 | 0.3432 |
Loa Loa (eye worm) | histone methyltransferase | 0.0009 | 0.051 | 0.051 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0011 | 0.0937 | 0.075 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.2346 | 0.2346 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.2346 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0019 | 0.2346 | 0.2188 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0042 | 0.6578 | 0.6578 |
Trypanosoma brucei | unspecified product | 0.0013 | 0.129 | 0.1887 |
Loa Loa (eye worm) | TAR-binding protein | 0.0061 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.3387 | 0.3387 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0019 | 0.2346 | 0.2188 |
Schistosoma mansoni | hypothetical protein | 0.0042 | 0.6578 | 0.6578 |
Onchocerca volvulus | 0.0028 | 0.4007 | 0.5 | |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0202 | 0.0202 |
Leishmania major | DNA polymerase eta, putative | 0.0044 | 0.6836 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.4295 | 0.4295 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.2346 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0044 | 0.6836 | 0.6771 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.2346 | 0.3432 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.3387 | 0.4955 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.4007 | 0.4007 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.4295 | 0.4295 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0011 | 0.0937 | 0.075 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.